New treatments for diabetic retinopathy

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Diabetes, obesity and metabolism

• Publication date

  2015-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/dom.12384PMID 25160598
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cost-effectiveness of Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema Treatment: Analysis From the Diabetic Retinopathy Clinical Research Network Comparative Effectiveness Trial.

  2016cited by this paper
• Intravitreal Ranibizumab for diabetic macular edema with prompt versus deferred laser treatment: 5-year randomized trial results.

  2015cited by this paper
• 12-month results of the standardised combination therapy for diabetic macular oedema: intravitreal bevacizumab and navigated retinal photocoagulation

  2014cited by this paper
• A review of anti-VEGF agents for proliferative diabetic retinopathy

  2014cited by this paper
• Sustained delivery fluocinolone acetonide vitreous implants: long-term benefit in patients with chronic diabetic macular edema.

  2014cited by this paper
• Ranibizumab for edema of the macula in diabetes study: 3-year outcomes and the need for prolonged frequent treatment.

  2013cited by this paper
• Progression of diabetic retinopathy in the hypertension intervention nurse telemedicine study.

  2013cited by this paper
• Optos‐guided pattern scan laser (Pascal)‐targeted retinal photocoagulation in proliferative diabetic retinopathy

  2013cited by this paper
• Long-term outcomes of ranibizumab therapy for diabetic macular edema: the 36-month results from two phase III trials: RISE and RIDE.

  2013cited by this paper
• Chapter 45 – The Epidemiology of Diabetic Retinopathy

  2013cited by this paper
• Pilot randomised clinical trial of Pascal TargETEd Retinal versus variable fluence PANretinal 20 ms laser in diabetic retinopathy: PETER PAN study

  2012cited by this paper
• Diabetic Retinopathy and Inflammation: Novel Therapeutic Targets

  2012cited by this paper
• Sustained delivery fluocinolone acetonide vitreous inserts provide benefit for at least 3 years in patients with diabetic macular edema.

  2012cited by this paper
• Intravitreal ranibizumab for diabetic macular edema with prompt versus deferred laser treatment: three-year randomized trial results.

  2012cited by this paper
• Global Prevalence and Major Risk Factors of Diabetic Retinopathy

  2012cited by this paper
• Subthreshold diode laser micropulse photocoagulation for the treatment of diabetic macular edema

  2012cited by this paper
• A potential role for angiopoietin 2 in the regulation of the blood-retinal barrier in diabetic retinopathy.

  2011cited by this paper
• Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials

  2011cited by this paper
• CC Chemokines Play an Important Role in Alteration of The Blood-Retinal Barrier in Diabetes

  2011cited by this paper
• Rationale for the diabetic retinopathy clinical research network treatment protocol for center-involved diabetic macular edema.

  2011cited by this paper
• Randomized clinical trial evaluating mETDRS versus normal or high-density micropulse photocoagulation for diabetic macular edema.

  2011cited by this paper
• Differential association of serum lipids with diabetic retinopathy and diabetic macular edema.

  2011cited by this paper
• Clinical evaluation and treatment accuracy in diabetic macular edema using navigated laser photocoagulator NAVILAS.

  2011cited by this paper
• Single-session vs multiple-session pattern scanning laser panretinal photocoagulation in proliferative diabetic retinopathy: The Manchester Pascal Study.

  2010cited by this paper
• Effects of medical therapies on retinopathy progression in type 2 diabetes.

  2010cited by this paper
• Infliximab for Diabetic Macular Edema Refractory to Laser Photocoagulation

  2010cited by this paper
• Vitrectomy outcomes in eyes with diabetic macular edema and vitreomacular traction.

  2010cited by this paper
• A prospective randomized trial of intravitreal bevacizumab or laser therapy in the management of diabetic macular edema (BOLT study) 12-month data: report 2.

  2010cited by this paper
• Barely visible 10-millisecond pascal laser photocoagulation for diabetic macular edema: observations of clinical effect and burn localization.

  2010cited by this paper
• MICROPERIMETRY AND FUNDUS AUTOFLUORESCENCE IN DIABETIC MACULAR EDEMA: Subthreshold Micropulse Diode Laser Versus Modified Early Treatment Diabetic Retinopathy Study Laser Photocoagulation

  2010cited by this paper
• Laser tissue interactions.

  2010cited by this paper
• Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema

  2010cited by this paper
• The prevalence of retinopathy in men with Type 2 diabetes and obstructive sleep apnoea

  2010cited by this paper
• Vegf and Pedf Secretions Over Time Following Various Laser Irradiations on an Rpe Organ Culture

  2010cited by this paper
• Plasma Kallikrein and Diabetic Macular Edema

  2010cited by this paper
• Prevalence of Retinopathy in Men with Type 2 Diabetes and Obstructive Sleep Apnoea.

  2009cited by this paper
• Pain response and follow-up of patients undergoing panretinal laser photocoagulation with reduced exposure times

  2008cited by this paper
• Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial.

  2008cited by this paper
• Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials.

  2008cited by this paper
• Prospective randomised controlled trial comparing sub-threshold micropulse diode laser photocoagulation and conventional green laser for clinically significant diabetic macular oedema

  2008cited by this paper
• Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial.

  2007cited by this paper
• Overview of epidemiologic studies of diabetic retinopathy.

  2007cited by this paper
• VISUAL SIDE EFFECTS OF SUCCESSFUL SCATTER LASER PHOTOCOAGULATION SURGERY FOR PROLIFERATIVE DIABETIC RETINOPATHY: A Literature Review

  2007cited by this paper
• Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy.

  2006cited by this paper
• SEMIAUTOMATED PATTERNED SCANNING LASER FOR RETINAL PHOTOCOAGULATION

  2006cited by this paper
• A pilot study of multiple intravitreal injections of ranibizumab in patients with center-involving clinically significant diabetic macular edema.

  2006cited by this paper
• The pathobiology of diabetic complications: a unifying mechanism.

  2005cited by this paper
• Subthreshold micropulse diode laser treatment in diabetic macular oedema

  2004cited by this paper
• Subthreshold diode micropulse photocoagulation for the treatment of clinically significant diabetic macular oedema

  2004cited by this paper
• Retinal and choroidal angiogenesis: pathophysiology and strategies for inhibition.

  2003cited by this paper
• The long-term effects of laser photocoagulation treatment in patients with diabetic retinopathy: the early treatment diabetic retinopathy follow-up study.

  2003cited by this paper
• Angiotensin II and vascular endothelial growth factor in the vitreous fluid of patients with diabetic macular edema and other retinal disorders.

  2002cited by this paper
• Pigment epithelium-derived factor suppresses ischemia-induced retinal neovascularization and VEGF-induced migration and growth.

  2002cited by this paper
• Leukocyte-mediated endothelial cell injury and death in the diabetic retina.

  2001cited by this paper
• [Diabetic retinopathy].

  2001cited by this paper
• The UK prospective diabetes study (UKPDS): clinical and therapeutic implications for type 2 diabetes.

  1999cited by this paper
• Vascular Endothelial Growth Factor Induces Rapid Phosphorylation of Tight Junction Proteins Occludin and Zonula Occluden 1

  1999cited by this paper
• Risk factors for high-risk proliferative diabetic retinopathy and severe visual loss: Early Treatment Diabetic Retinopathy Study Report #18.

  1998cited by this paper
• The Diabetes Control and Complications Trial

  1998cited by this paper
• Laser-tissue interactions.

  1995cited by this paper
• Diabetic retinopathy

  1995cited by this paper
• The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

  1993cited by this paper
• Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS report number 12. Early Treatment Diabetic Retinopathy Study Research Group.

  1991cited by this paper
• Early vitrectomy for severe vitreous hemorrhage in diabetic retinopathy. Four-year results of a randomized trial: Diabetic Retinopathy Vitrectomy Study Report 5.

  1990cited by this paper
• [Epidemiology of diabetic retinopathy].

  1988cited by this paper
• ATP causes retinal pericytes to contract in vitro.

  1988cited by this paper
• Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group.

  1985cited by this paper
• The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years.

  1984cited by this paper
• The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years.

  1984cited by this paper
• Photocoagulation treatment of proliferative diabetic retinopathy. Clinical application of Diabetic Retinopathy Study (DRS) findings, DRS Report Number 8. The Diabetic Retinopathy Study Research Group.

  1981cited by this paper
• Retinal vascular patterns. VI. Mural cells of the retinal capillaries.

  1963cited by this paper
• Photocoagulation

  1962cited by this paper

• IMPROVING DIABETIC RETINOPATHY SCREENING USING ARTIFICIAL INTELLIGENCE TECHNOLOGY

  2026cites this paper
• Revolutionizing drug delivery strategies with probucol to Combat oxidative stress in retinal Degeneration: A comprehensive review.

  2025cites this paper
• Mechanisms of action of retinal microglia in diabetic retinopathy (Review)

  2025cites this paper
• The glucocorticoid receptor as a master regulator of the Müller cell response to diabetic conditions in mice

  2024cites this paper
• Investigating the impact of empagliflozin on the retina of diabetic mice

  2024cites this paper
• Diabetes and infection: review of the epidemiology, mechanisms and principles of treatment

  2024cites this paper
• Therapeutic potential of flavopiridol in diabetic retinopathy: Targeting DDX58.

  2024cites this paper
• Advances in retinal microaneurysms detection, segmentation and datasets for the diagnosis of diabetic retinopathy: a systematic literature review

  2024cites this paper
• Advances in Research Related to MicroRNA for Diabetic Retinopathy

  2024cites this paper
• Implications of Caspase 1/ Interleukin-1 Beta (IL-1β) Signaling and Hypoxia-Inducible Factor 1-Alpha (HIF-1α) on Diabetic Retinopathy Pathology

  2023influential citation
• Recent Advancement of Nanomedicine for Diabetic Retinopathy: A Review

  2023cites this paper
• Overview: Versatility of curcumin in management of diabetic retinopathy

  2023cites this paper
• The glucocorticoid receptor as a master regulator of Müller cell gliosis in the diabetic retina

  2023cites this paper
• Ameliorative effect of black raspberry anthocyanins on diabetes retinopathy by inhibiting axis protein tyrosine phosphatase 1B-endoplasmic reticulum stress

  2023cites this paper
• Acylcarnitines in Ophthalmology: Promising Emerging Biomarkers

  2022cites this paper
• Norkurarinone and isoxanthohumol inhibit high glucose and hypoxia-induced angiogenesis via improving oxidative stress and regulating autophagy in human retinal microvascular endothelial cells.

  2022cites this paper
• Advances in cell therapies using stem cells/progenitors as a novel approach for neurovascular repair of the diabetic retina

  2022cites this paper
• Berberis dictyophylla F. inhibits angiogenesis and apoptosis of diabetic retinopathy via suppressing HIF-1α/VEGF/DLL-4/Notch-1 pathway.

  2022cites this paper
• Diabetic Retinopathy: An Overview of Treatments

  2022cites this paper
• Th22 cells induce Müller cell activation via the Act1/TRAF6 pathway in diabetic retinopathy

  2022influential citation
• A Nonrandomized Phase 2 Trial of EG-Mirotin, a Novel, First-in-Class, Subcutaneously Deliverable Peptide Drug for Nonproliferative Diabetic Retinopathy

  2022cites this paper
• Hub Genes Associated with the Diagnosis of Diabetic Retinopathy

  2021cites this paper
• Non-invasive multimodal imaging of Diabetic Retinopathy: A survey on treatment methods and Nanotheranostics

  2021influential citation
• Intravitreal administration of recombinant human opticin protects against hyperoxia-induced pre-retinal neovascularization

  2021cites this paper
• MicroRNA-139-5p Alleviates High Glucose-Triggered Human Retinal Pigment Epithelial Cell Injury by Targeting LIM-Only Factor 4

  2021cites this paper
• Systematic review and Meta-analysis of 26 randomized controlled clinical trials of Compound Danshen Dripping Pill for non-proliferating diabetic retinopathy

  2021cites this paper
• High-risk coronary artery plaque in asymptomatic patients with type 2 diabetes: clinical risk factors and coronary artery calcium score

  2021cites this paper
• Automated microaneurysms detection for early diagnosis of diabetic retinopathy: A Comprehensive review

  2021cites this paper
• Oculocardiac Reflex During Intravitreal Injection

  2020cites this paper
• Calcitriol and non-calcemic vitamin D analogue, 22-oxacalcitriol, attenuate developmental and pathological choroidal vasculature angiogenesis ex vivo and in vivo

  2020cites this paper
• Visual Acuity Outcomes after Cataract Extraction with Intraocular Lens Implantation in Eyes with Diabetic Retinopathy.

  2020cites this paper
• Transcriptomics analysis of pericytes from retinas of diabetic animals reveals novel genes and molecular pathways relevant to blood-retinal barrier alterations in diabetic retinopathy.

  2020cites this paper
• Xueshuantong for Injection (Lyophilized, 注射用血栓通) Alleviates Streptozotocin-Induced Diabetic Retinopathy in Rats

  2020cites this paper
• Ginsenoside Re Attenuates High Glucose-Induced RF/6A Injury via Regulating PI3K/AKT Inhibited HIF-1α/VEGF Signaling Pathway

  2020cites this paper
• Diabetic retinopathy: history, modern approaches to management, prospective views of prevention and treatment

  2020cites this paper
• A Comprehensive Review on Diabetic Retinopathy and Mental Disorders

  2020cites this paper
• Formulation of PPAR-gamma agonist as surface modified PLGA nanoparticles for non-invasive treatment of diabetic retinopathy: in vitro and in vivo evidences

  2020cites this paper
• Z-Ligustilide Ameliorates Diabetic Rat Retinal Dysfunction Through Anti-Apoptosis and an Antioxidation Pathway

  2020cites this paper
• Diabetic Retinopathy: Important Biochemical Alterations and the Main Treatment Strategies.

  2020cites this paper
• Metabolic Dysregulation and Neurovascular Dysfunction in Diabetic Retinopathy

  2020cites this paper
• Calcitriol and Non-Calcemic Vitamin D Analogue, 22-Oxacalcitriol, Attenuate Developmental and Pathological Ocular Angiogenesis Ex Vivo and In Vivo

  2019cites this paper
• Pericyte Bridges in Homeostasis and Hyperglycemia: Reconsidering Pericyte Dropout and Microvascular Structures

  2019cites this paper
• [Effect of intravitreal injections of ranibizumab and aflibercept on the retinal nerve fiber layer in patients with concomitant neovascular age-related macular degeneration and glaucoma].

  2019cites this paper
• Challenges and opportunities for drug delivery to the posterior of the eye.

  2019cites this paper
• The role of Müller cell glucocorticoid signaling in diabetic retinopathy

  2019cites this paper
• EFFECTS OF SUB-TENON STERIOD IN PAN RETINAL PHOTOCOAGULATION IN DIABETIC RETINOPATHY

  2018cites this paper
• 50 – The eye

  2018cites this paper
• The Role of Microglia in Diabetic Retinopathy: Inflammation, Microvasculature Defects and Neurodegeneration

  2018cites this paper
• Role of histone modification and DNA methylation in signaling pathways involved in diabetic retinopathy

  2018cites this paper
• Increased serum periostin concentrations are associated with the presence of diabetic retinopathy in patients with type 2 diabetes mellitus

  2018cites this paper
• Therapeutic regulation of VE-cadherin with a novel oligonucleotide drug for diabetic eye complications using retinopathy mouse models

  2018cites this paper
• Modulation of three key innate immune pathways for the most common retinal degenerative diseases

  2018cites this paper
• Lipid‐lowering medication is associated with decreased risk of diabetic retinopathy and the need for treatment in patients with type 2 diabetes: A real‐world observational analysis of a health claims database

  2018influential citation
• Proteinuria and Renal Dysfunction after Intravitreal Injection of Bevacizumab in Patients with Diabetic Nephropathy: A Prospective Observational Study

  2018cites this paper
• Retinal Nerve Fiber Layer Thickness in Glaucoma Patients Treated with Multiple Intravitreal Anti-Vegf (Bevacizumab) Injections.

  2017cites this paper
• Pathogenic Role of microRNA-21 in Diabetic Retinopathy Through Downregulation of PPARα

  2017cites this paper
• Long Term Ocular Drug Delivery with Novel Pentablock Copolymers; Part I: Composite Nanoformulation of Macromolecules For Back of the Eye Diseases, Part II: Dexamethasone Nanoparticle to Develop an In Vitro Model for Glaucoma

  2017cites this paper
• Treatment of Diabetic Retinopathy: A Historical Perspective

  2017cites this paper
• Morphological Plasticity of Emerging Purkinje Cells in Response to Exogenous VEGF

  2017cites this paper
• How to prevent the microvascular complications of type 2 diabetes beyond glucose control

  2017cites this paper
• Plasma level of miR-93 is associated with higher risk to develop type 2 diabetic retinopathy

  2017cites this paper
• The pathology associated with diabetic retinopathy

  2017cites this paper
• DIABETIC RETINOPATHY: ITS MECHANISM AND THERAPEUTIC STRATEGIES

  2016cites this paper
• Diabetic Retinopathy: Animal Models, Therapies, and Perspectives

  2016cites this paper
• Global metabolomics reveals metabolic dysregulation in ischemic retinopathy

  2015cites this paper
• Beta-adrenergic receptor agonist decreases VEGF levels through altered eNOS and PKC signaling in diabetic retina

  2015influential citation
• Novel therapeutic approaches for diabetic nephropathy and retinopathy.

  2015cites this paper
• Focusing on metabolomic dysregulation and modulation of retinal metabolism to develop novel therapeutic strategies for diabetic retinopathy

  2015influential citation
• Neuroinflammatory responses in diabetic retinopathy

  2015cites this paper